What does Jazz Pharma (JAZZ) Combined with GW Pharma (GWPH) Look Like?, PT Raised to $202 at Stifel
Tweet Send to a Friend
Stifel analyst Annabel Samimy raised the price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) to $202.00 (from $195.00) after integrating JAZZ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
